Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
NAD+ Precursors (NMN & NR): Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after NAD+ Precursors (NMN & NR) therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to NAD+ Precursors (NMN & NR) overviewBefore Starting (2 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| Metabolic Panel | → normalizes | Every 12 weeks |
| ALT/AST | → normalizes | Every 12 weeks |
During Treatment (1 test)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| NAD+ (blood) | ↑ increases | Every 4 weeks |